ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 85 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,511,286 | -10.1% | 20,763,323 | +26.2% | 0.55% | -10.6% |
| Q2 2023 | $106,268,163 | +34.9% | 16,450,180 | +57.4% | 0.62% | +43.4% |
| Q1 2023 | $78,794,357 | -25.6% | 10,450,180 | 0.0% | 0.43% | -32.5% |
| Q4 2022 | $105,860,323 | +2.4% | 10,450,180 | 0.0% | 0.64% | -6.1% |
| Q3 2022 | $103,352,000 | -7.1% | 10,450,180 | 0.0% | 0.68% | +7.3% |
| Q2 2022 | $111,294,000 | +9.2% | 10,450,180 | 0.0% | 0.63% | +7.9% |
| Q1 2022 | $101,889,000 | -31.8% | 10,450,180 | 0.0% | 0.58% | -19.5% |
| Q4 2021 | $149,438,000 | -28.6% | 10,450,180 | 0.0% | 0.73% | -21.0% |
| Q3 2021 | $209,422,000 | -8.9% | 10,450,180 | 0.0% | 0.92% | -8.9% |
| Q2 2021 | $229,904,000 | -35.2% | 10,450,180 | 0.0% | 1.01% | -34.4% |
| Q1 2021 | $354,888,000 | -15.6% | 10,450,180 | 0.0% | 1.54% | -2.8% |
| Q4 2020 | $420,515,000 | – | 10,450,180 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |